Role of immunoglobulins in neonatal sepsis

L Capasso, Ac Borrelli, J Cerullo, R Pisanti, C Figliuolo, F Izzo, M Paccone, T Ferrara, S Lama, F Raimondi, L Capasso, Ac Borrelli, J Cerullo, R Pisanti, C Figliuolo, F Izzo, M Paccone, T Ferrara, S Lama, F Raimondi

Abstract

Neonates, especially VLBW, are at high risk for sepsis related morbidity and mortality for immaturity of their immune system and invasive NICU practices. The paucity of immunoglobulins in preterm neonates consequently to the immaturity of immune system contributes to their high risk for systemic infection. The use of intravenous IgM enriched immunoglobulins, with higher antimicrobial activity than standard IgG, has been demonstrated in a retrospective study to reduce short term mortality in VLBW infant with proven sepsis. Larger, randomized prospective trials given the enormous burden of morbidity and mortality imposed by neonatal sepsis should urgently be addressed not only to validate this results but also to tailor the optimal scheme of treatment.

Keywords: immunoglobulins; neonate; sepsis.

Figures

Figure 1.
Figure 1.
Main pathogens isolated from blood cultures

References

    1. Ohlsson A, Lacy J. The Cochrane Library. Oxford: 2010. Update software; Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants (Cochrane Review).
    1. Bizzarro MJ, Raskind C, Baltimore R, Gallangher PG. Seventy-Five years of neonatal sepsis at Yale: 1928–2003. Pediatrics. 2005;116:595–602.
    1. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clinical Microbiology Reviews. 2004 Jul;17(3):638–680.
    1. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics. 1981;68:544–549.
    1. Wilson CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr. 1986;108:1–12.
    1. Raimondi F, Ferrara T, Maffucci R, Milite P, Del Buono D, Santoro P, et al. Neonatal sepsis: A difficult diagnostic challenge Clin Biochem. 2011 May;44(7):463–4.
    1. Kapur R, Yoder MC, Polin RA. The Immune System: developmental Immunology. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Neonatal Perinatal Medicine. Diseases of the Fetus and Infant. Elsevier Mosby; 2006.
    1. Sharp & Dohme Italia S.p.A. Situazione immunologica del feto. Edizione Italiana. 2006. Manuale Merck, sez. Pediatria.
    1. Edwards WH, Conner JM, Soll RF, for the Vermont Oxford Network Neonatal Skin Care Study Group The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weights of 501 to 1000 g. Pediatrics. 2004;113:1195–1203.
    1. Mallow EB, Harris A, Salzman N, Russel JP, DeBerardinis RJ, Ruchelli E, et al. Human enteric defensins. Gene structure and developmental expression. J Biol Chem. 1996;271:4038–4045.
    1. Rognum TO, Thrane S, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res. 1992;32:145–149.
    1. Campi F, Laurenti F. Infezioni: Immunologia feto-neonatale. In: Bucci G, Marzetti G, Mendicini M, editors. Neonatologia. Il Pensiero Scientifico editore; 1999.
    1. Christensen RD, Henry E, Wiedmeier SE, Stoddard RA, Lambert DK. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system. Perinatol. 2006 Nov;26(11):682–7. Epub 2006 Oct 12.
    1. Yachie A, Takano N, Ohta K, Uehara T, Fujita S, Miyawaki T, et al. Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens. Infect Immun. 1992;60:749–753.
    1. English BK, Hammond WP, Lewis DB, Brown CB, Wilson CB. Decreased granulocyte-macrophage colony-stimulating factor production by human neonatal blood mononuclear cells and T cells. Pediatr Res. 1992;31:211–26.
    1. Buckley RH. The Immunologic System and Disorders: T Lymphocytes, B Lymphocytes, and Natural Killer Cells. In: Richard E, Behrman MD, Robert M, Kliegman MD, Hal B, Jenson MD, editors. Nelson Text Book of Pediatrics. 17th Ed. SAUNDERS An Imprint of Elsevier Science; 2004.
    1. Holt PG. Developmental factors as determinats of risk for infections and atopy in childhood. Eur Respir Rev. 2005;14(95):69–73.
    1. Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood. 1994;84:4333–4343.
    1. Borras FE, Matthews NC, Lowdell MW, Navarrete CV. Identification of both myeloid CD11c+ and lymphoid CD11c-dendritic cell subsets in cord blood. Br J Haematol. 2001;113:925–931.
    1. Trivedi HN, Hayglass KT, Gangur V, Allardice JG, Embree JE, Plummer FA. Analysis of neonatal T cell antigen presenting cell functions. Hum Immunol. 1997;57:69–79.
    1. Stabile I, Nicolaides KH, Bach A, Teisner B, Rodeck C, Westergaard JG, et al. Complement factors in fetal and maternal blood and amniotic fluid during the second trimester of normal pregnancy. Br J Obstet Gynaecol. 1988 Mar;95(3):281–5.
    1. Propp RP, Alper CA. C’3 synthesis in the human fetus and lack of transplacental passage. Science. 1968 Nov 8;162(854):672–3.
    1. Johnston RB, Jr, Altenburger KM, Atkinson AW, Jr, Curry RH. Complement in the Newborn Infant. Pediatrics. 1979 Nov;64(5):781–786.
    1. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006 Apr;28(3):178–82. Epub 2005 Sep 21.
    1. Adinolfi M, Lessof MH. Development of humoral and cellular immunity in man. Journal of Medical Genetic. 1972;9:86.
    1. Ballow M, Cates KL, Rowe JC, Goetz C, Desbonnet C. Development of the immune system in very low birth weigth (less than 1500 g) premature infants:concentrations of plasma immunoglobulins and patterns of infection. Pediatr Res. 1986;20:899–904.
    1. Gotoroff SP. Infezioni nel neonato. In: Nelson WE, Behrman RE, Kliegman RM, Jenson HB, editors. Trattato di pediatria. Edizioni Minerva Medica; 2002.
    1. Tarnow-Mordi W, Isaacs D, Dutta S. Adjunctive Immunologic Interventions in Neonatal Sepsis. Clin Perinatol. 2010;37:481–499.
    1. Haque KN, Remo C, Bahakim H. Comparison of two types of intravenous immunoglobulins in treatment of neonatal sepsis. Clin Exp Immunol. 1995;101:328–333.
    1. Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics. 1997 Feb;99(2):E2.
    1. Norby-Teglund A, Haque KN, Hammarström L. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. Journal of International Medicine. 2006;260:509–516.
    1. Ohlsson A, Lacy J. The Cochrane Library. Oxford: 2010. Update software; Intravenous immunoglobulin for suspected or subsequently proven infection in neonates (Cochrane Review).
    1. The INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl Med. 2011;365:1201.
    1. Stehr SN, Knels L, Weissflog C, Schober J, Haufe D, Lupp A, et al. Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock. 2008 Feb;29(2):167–72.
    1. Schedel I, Dreikhausen U, Nentwig B, Höckenschnieder M, Rauthmann D, Balikcioglu S, et al. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit care Med. 1991;19:1004–13.
    1. Rodríguez A, Rello J, Neira J, Maskin B, Ceraso D, Vasta L, et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock. 2005 Apr;23(4):298–304.
    1. Reith HB, Rauchschwalbe SK, Mittelkötter U, Engemann R, Thiede A, Arnold A, et al. IgM-enriched immunoglobulin (pentaglobin) positively influences the course of post-surgical intra-abdominal infections. Eur J Med Res. 2004 Oct 29;9(10):479–84.
    1. Neilson AR, Burchardi H, Schneider H. Cost-effectiveness of immunoglobulin M-enriched (Pentaglobin) in the treatment of severe sepsis and septic shock. Journal of critical care. 2005;20:239–250.
    1. Haque KN, Zaidi MH, Bahakim H. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child. 1988;142(12):1293–6.
    1. Capasso L, Borrelli AC, Parrella P, Lama S, Ferrara T, Coppola C, et al. Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants? Ital J Pediatr. 2013 Oct 7;39:63.
    1. Vermont Oxford Network Database release 15.1 Manual of Operations part 2: data definitions, data forms and submission timeline for infants born in 2011. Published January 2011.
    1. Richardson DK, Concoran JD, Escobar GJ, Lee SK. SNAP II and SNAPPE II: simplified newborn illness severity and mortality risk scores. J Pediatrics. 2001;138:92–100.
    1. Sundaram V, Dutta S, Ahluwalia J, Narag A. Score for Neonatal Acute Physiology II predicts mortality and persistent organ disfunction in neonates with severe septicemia. Indian Pediatrics. 2009 Sep;46:775–80.
    1. Norby-Teglund A, Ihendyane N, Kansal R, Basma H, Kotb M, Andersson J, et al. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens. Clin Inf Dis. 2000;31:1175–82.
    1. Shoham S, Levitz SM. The immuno response to fungal infections. Br J Haematol. 2005;129:569.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit